Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivien Hebert

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Immunotherapy|October 25, 2017
Rituximab in pemphigusVivien Hebert, Pascal Joly
JAAD Case Reports|January 24, 2019
Linear IgA bullous dermatosis treated with rituximabCamille Pinard, Vivien Hebert, Myriam Lecuyer, et al.
JAAD Case Reports|September 30, 2020
Severe dapsone-induced hypoalbuminemia in a case of mucous membrane pemphigoidJasmine Flament, Lamia Jelti, Catherine Lok, et al.
JAAD Case Reports|June 27, 2022
Botryoid connective tissue nevi: An uncommon presentation of hamartoma of the skinEmma Huard, Margot Raynal, Sylvie Fraitag, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 5, 2019
Senegal, a new potential endemic country for Buruli ulcer?Lucie Dupechez, Priscille Carvalho, Vivien Hebert, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 9, 2024
Efficacy of virtual reality on pain and anxiety management in dermatological proceduresJeanne Guillet, Billal Tedbirt, Vivien Hebert, et al.
Journal of the American Academy of Dermatology|February 19, 2017
Sensitivity and specificity of BP180 NC16A enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationisFatimah Al Saif, Fabienne Jouen, Vivien Hebert, et al.
JID Innovations : Skin Science From Molecules to Population Health|July 21, 2022
How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International SurveyMarine Guignant, Billal Tedbirt, Dedee F Murrell, et al.
The Journal of Investigative Dermatology|December 14, 2018
Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General PopulationMarthe Plaquevent, Florence Tétart, Laurence Fardet, et al.
Lancet (London, England)|March 27, 2017
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trialPascal Joly, Maud Maho-Vaillant, Catherine Prost-Squarcioni, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Immunotherapy|October 25, 2017
Rituximab in pemphigusVivien Hebert, Pascal Joly
JAAD Case Reports|January 24, 2019
Linear IgA bullous dermatosis treated with rituximabCamille Pinard, Vivien Hebert, Myriam Lecuyer, et al.
JAAD Case Reports|September 30, 2020
Severe dapsone-induced hypoalbuminemia in a case of mucous membrane pemphigoidJasmine Flament, Lamia Jelti, Catherine Lok, et al.
JAAD Case Reports|June 27, 2022
Botryoid connective tissue nevi: An uncommon presentation of hamartoma of the skinEmma Huard, Margot Raynal, Sylvie Fraitag, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 5, 2019
Senegal, a new potential endemic country for Buruli ulcer?Lucie Dupechez, Priscille Carvalho, Vivien Hebert, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 9, 2024
Efficacy of virtual reality on pain and anxiety management in dermatological proceduresJeanne Guillet, Billal Tedbirt, Vivien Hebert, et al.
Journal of the American Academy of Dermatology|February 19, 2017
Sensitivity and specificity of BP180 NC16A enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationisFatimah Al Saif, Fabienne Jouen, Vivien Hebert, et al.
JID Innovations : Skin Science From Molecules to Population Health|July 21, 2022
How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International SurveyMarine Guignant, Billal Tedbirt, Dedee F Murrell, et al.
The Journal of Investigative Dermatology|December 14, 2018
Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General PopulationMarthe Plaquevent, Florence Tétart, Laurence Fardet, et al.
Lancet (London, England)|March 27, 2017
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trialPascal Joly, Maud Maho-Vaillant, Catherine Prost-Squarcioni, et al.
Pageof 1